Cyclomune Eye Drop (Cyclosporine) – Product Overview

Cyclomune Eye Drop is a prescription ophthalmic solution manufactured by Sun Pharmaceutical Industries Ltd. Each bottle contains 3 ml of a clear, isotonic preparation that delivers cyclosporine, an immunosuppressant medication, directly to the ocular surface. The product is specifically indicated for the treatment of chronic dry eye disease, a condition characterized by insufficient tear production or excessive tear evaporation.

What is Cyclomune Eye Drop

Cyclomune Eye Drop contains cyclosporine as the active ingredient, a calcineurin inhibitor that modulates the immune response on the ocular surface. Although the product name references cyclosporin, the pharmaceutical formulation uses the active metabolite cyclosporine to achieve therapeutic levels in the tear film. This medication belongs to the class of immunomodulatory agents used topically to increase tear production in patients with dry eye who have not responded adequately to artificial tears alone.

Uses and Benefits

Patients use Cyclomune Eye Drop to relieve the burning, itching, and foreign‑body sensation associated with dry eye syndrome. Clinical studies have demonstrated that regular application can improve tear breakup time, increase Schirmer test values, and reduce ocular inflammation. Additional benefits include:

• Enhanced comfort for individuals who wear contact lenses
• Reduced reliance on frequent artificial tear use
• Potential to preserve corneal health by decreasing chronic inflammation

Because the formulation is preservative‑free, it minimizes the risk of preservative‑related irritation, making it suitable for long‑term therapy.

How It Works

The mechanism of action of cyclosporine eye drops involves penetration of the corneal epithelium and interaction with T‑cells in the conjunctiva. By inhibiting calcineurin, cyclosporine prevents the activation of interleukin‑2 and subsequent cytokine release, leading to a decrease in inflammatory cells and a restoration of normal tear film composition. Research published by the National Institutes of Health supports the efficacy of topical cyclosporine in increasing tear production and improving symptom scores in patients with moderate to severe dry eye disease.

Dosage Guidelines

For adults, the recommended dosage is one drop in each affected eye twice daily, typically every 12 hours. The dosing schedule may be adjusted by the prescribing clinician based on patient response and tolerance. Patients should:

1. Wash hands thoroughly before application.
2. Tilt the head back slightly and pull down the lower eyelid with a clean finger.
3. Instill a single drop into the conjunctival sac without touching the bottle tip to the eye.
4. Close the eye gently for a few seconds to allow even distribution.
5. Do not blink excessively immediately after dosing.
6. Do not use more drops than prescribed; excessive use does not enhance efficacy and may increase the risk of adverse effects.

Patients should follow the dosing instructions provided by their ophthalmologist or optometrist and should not share the medication with others.

Side Effects

Like all medications, Cyclomune Eye Drop can cause side effects. Most are mild and transient, including:

• Mild ocular burning or stinging immediately after instillation
• Temporary blurred vision
• Itching or redness of the eyelids
• Headache

Less common but more serious adverse events may include:

• Ocular infections such as conjunctivitis or keratitis
• Allergic reactions characterized by swelling, itching, or rash
• Systemic immunosuppression in rare cases of excessive absorption

Patients should discontinue use and contact their eye care professional if they experience severe pain, vision changes, or signs of infection.

Warnings and Precautions

Cyclomune Eye Drop is contraindicated in individuals with known hypersensitivity to cyclosporine or any component of the formulation. The medication should be used only under the supervision of a qualified eye care professional. Important precautions include:

• Keeping the bottle tightly closed and storing it at room temperature away from direct sunlight.
• Avoiding contamination of the dropper tip; never share the bottle with another person.
• Exercising caution if the patient is pregnant, planning pregnancy, or breastfeeding; discuss potential risks with a healthcare provider.
• Monitoring for signs of systemic immunosuppression if long‑term use is required.
• Consulting the U.S. Food and Drug Administration for the most current safety information.

Frequently Asked Questions

1. How long does it take to notice improvement in dry eye symptoms?

Most patients report a reduction in burning and itching within two to four weeks of consistent use. Full therapeutic effect may require up to 12 weeks, especially in cases of severe inflammation.

2. Can Cyclomune Eye Drop be used with other ocular medications?

Yes, but a minimum interval of five minutes should be maintained between instillation of Cyclomune and other eye drops to prevent dilution and to allow adequate absorption.

3. Is the product safe for contact lens wearers?

Cyclomune Eye Drop is preservative‑free and can be used by contact lens wearers. It is recommended to apply the drops before inserting lenses, and to remove lenses prior to dosing if irritation occurs.

4. What should I do if I miss a dose?

If a dose is missed, the patient should instill the missed drop as soon as remembered, unless it is close to the time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed.

5. Are there any dietary restrictions while using Cyclomune Eye Drop?

No specific dietary restrictions are required, as the medication is administered locally to the eye and has minimal systemic absorption.

Related Products

• Vortidif 20 Mg (Vortioxetine)
• Vortidif 5 Mg (Vortioxetine)
• Pramipex 0.25 mg (Pramipexole)
• Mirtaz 30 Mg (Mirtazapine)
• Lurasidone 40 mg (Generic)
• Ropinirole 1 mg (Generic)
• Adesam 200 mg (Ademetionine/S-Adenosyl Methionine)
• Suminat 25 mg (Sumatriptan)
• Syncapone 100 mg (Levodopa/Carbidopa/Entacapone)
• Glypride 4 mg (Glimepiride)
• Natrise 15 mg (Tolvaptan)
• Simvastatin 5 mg (Simvastatin)